- Tolerability, safety and pharmacokinetics of the FGLL peptide, a novel mimetic of neural cell adhesion molecule, following intranasal administration in healthy volunteersRavi Anand
Anand Pharma Consulting, Oberwil, Switzerland
Clin Pharmacokinet 46:351-8. 2007..This article reports on the results of the first administration of FGL(L) in humans...
- Electrocardiographic effects of rivastigmineJoel Morganroth
eResearch Technology, Philadelphia, PA 19103, USA
J Clin Pharmacol 42:558-68. 2002..Percentage change from baseline for PR, QRS, and QTc intervals was also no different. In conclusion, rivastigmine appears not to produce adverse effects on cardiac function assessed by ECG...